Plain-English translation of NCT06492070 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether cooling compression wraps โ used before, during, and after chemotherapy infusions โ can prevent peripheral neuropathy (nerve damage in the hands and feet) caused by a chemotherapy drug called . Some participants will also take , a medication that improves blood flow, to see if it further reduces nerve damage. The study will compare women who use cooling wraps alone, cooling wraps plus the medication, and those receiving standard care.
is an effective cancer treatment, but it commonly causes painful nerve damage that can last long after treatment ends and affect quality of life. This trial is exploring whether this medication, combined with a simple cooling strategy, can significantly reduce or prevent this side effect.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, you will receive chemotherapy over 6โ9 cycles as planned by your oncologist. On chemotherapy days, you will wear cooling compression wraps on your hands and feet for 15 minutes before, during, and after your infusion โ three times that day. If you are in the medication group, you will also take a pill twice daily starting with your first chemotherapy infusion and continuing for 2 weeks after your last infusion. The study team will regularly check how much nerve damage you develop and how the treatment affects your quality of life and side effects.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
United States